Related Experiment Videos

Risk stratification for sudden cardiac death: current approaches and predictive value

Gustavo Lopera1, Anne B Curtis

  • 1Division of Cardiology, University of Miami/Miller School of Medicine, Miami, FL, USA.

Current Cardiology Reviews
|January 13, 2010
PubMed

Insights

Sudden cardiac death (SCD) is a major public health concern. Current risk stratification, primarily using left ventricular ejection fraction (LVEF), is insufficient for identifying all at-risk patients.

Area of Science:

  • Cardiology
  • Public Health

Background:

  • Sudden cardiac death (SCD) poses a significant public health challenge, with high incidence rates in North America.
  • Current risk stratification methods, mainly relying on left ventricular ejection fraction (LVEF), are inadequate for identifying a broad spectrum of at-risk individuals.

Purpose of the Study:

  • To review the problem of sudden cardiac death.
  • To evaluate the clinical utility of various risk stratification markers for SCD.
  • To explore the potential of combining markers for improved risk assessment.

Main Methods:

  • Literature review of existing risk stratification strategies for sudden cardiac death.
  • Analysis of the role of left ventricular ejection fraction (LVEF) as a primary risk marker.
  • Discussion of emerging and complementary risk stratification tools.

Main Results:

  • Left ventricular ejection fraction (LVEF) <35% is a key indicator for prophylactic ICD implantation in heart failure patients.
  • Existing strategies often fail to identify a larger population at risk for SCD.
  • The optimal approach and value of combined risk stratification tools require further clarification.

Conclusions:

  • Improved risk stratification is crucial for reducing SCD incidence.
  • Further research is needed to validate and integrate novel markers into clinical practice.
  • A multifaceted approach combining multiple risk stratification tools may enhance patient identification and prevention strategies.

Keywords:
Sudden cardiac deathrisk stratification markers.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Actuarial Approach01:20

Actuarial Approach

The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...